Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Alzheimer’s Disease
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • UZEDY: Information from Industry
  • View All
Back to top Open menu arrow
Download PDF Reprints
No sections available

The Primary
Care Companionfor CNS Disorders

Free access
Schizophrenia/Schizoaffective Disorders

Letter to the Editor October 16, 2006

Mirtazapine-Induced Nightmares

Babatunde Adetunji, M.D.; Biju Basil, M.D.; Maju Mathews, M.D.; Harun Evcimen, M.D.; Sunil Joseph, M.D.

Prim Care Companion J Clin Psychiatry 2006;8(5):311-311

Article Abstract

Letter to the Editor

Mirtazapine-Induced Nightmares

About the Authors

  • Babatunde Adetunji, M.D.
    View full profile
  • Biju Basil, M.D.
    View full profile
  • Maju Mathews, M.D.
    View full profile
  • Harun Evcimen, M.D.
    View full profile
  • Sunil Joseph, M.D.
    View full profile
Download Free PDF

This PDF is free for all visitors!

Announcement: The Journal of Clinical Psychiatry launches a new podcast. Click to learn more.

Related JCP Articles

Clinical pearls of early use of Xanomeline–Trospium in the in-patient setting with Michael Halassa MD, PhD Latency to LAI Antipsychotic Initiation and Psychiatric Hospitalization in First-Episode Schizophrenia Rationale for Clozapine Trial

Related PCC Articles

Cotard Syndrome in Schizophrenia Tetrabenazine-Induced Suicidality Psychosis Screening in Genetic Disorders
Figure—Magazine cover highlights articles on suicide attempts, family support, impulsivity, grief, and bipolar disorder care.

Vol 28 • 2026 • Number 1

Read the Current Issue

Original Research

Suicidal Mental Imagery in Suicide Attempters

Original Research

Family Support for Patients With Substance Use Disorders

Rounds in the General Hospital

Diagnosing and Treating Impulsivity

Rounds in the General Hospital

Managing Grief and Bereavement

Brief Report

Measurement-Based Care for Bipolar Disorder

Rounds in the General Hospital

Treatment and Referral for AUD in Primary Care

View current Issue

Related Articles

JCP
Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?
Letter to the Editor

Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?

March 20, 2024

As choice of administration route is crucial during psychiatric emergencies, the authors stress the need for RCTs comparing onset of efficacy for agitation across different administration routes of the...
Xintong Mu, Hiroyoshi Takeuchi
JCP
Asenapine, Aggression, and Affinity
Letter to the Editor

Asenapine, Aggression, and Affinity

September 28, 2022

Dr El-Mallakh comments on a recent study by Citrome et al and discusses his group’s research on antiaggression effects of clozapine.
Rif S. El-Mallakh
JCP
A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole
Letter to the Editor

A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole

August 3, 2022

This letter comments on methodological aspects of a recent study by Cohen et al.
Barbara Mintzes, Alain Braillon, Florian Naudet, et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • THREADS
  • BLUESKY
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2026 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap